NRx Pharmaceuticals CFO William Fricker to leave Aug 30; James Brandon named Acting CFO

NRX Pharmaceuticals, Inc.

William Fricker to depart as CFO and Treasurer effective August 30, 2021; no disagreements cited.
James Brandon to serve as Comptroller and Acting CFO; Alessandra Daigneault as Acting Treasurer.
Ira Strassberg hired as financial consultant to lead CFO recruitment; previously Deputy CFO of Cantor Fitzgerald.
Fricker will receive a $100,000 annual bonus for completing his employment contract.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

James Brandon

Comptroller and Acting Chief Financial Officer

NRXP · NRX Pharmaceuticals, Inc.

Effective: 2021-08-18
Filed: August 19, 2021, 7:59 PM ET

James Brandon, who served as Comptroller and Acting CFO for NeuroRx, Inc. since inception through 2020, will resume those duties

Appointed (interim)

Alessandra Daigneault

Acting Treasurer

NRXP · NRX Pharmaceuticals, Inc.

Effective: 2021-08-18
Filed: August 19, 2021, 7:59 PM ET

Alessandra Daigneault, the Company’s General Counsel and Corporate Secretary will serve as Acting Treasurer.

Departed (interim)

William Fricker

Chief Financial Officer (CFO) and Treasurer

NRXP · NRX Pharmaceuticals, Inc.

Effective: 2021-08-30
Successor: James Brandon
Filed: August 19, 2021, 7:59 PM ET

announced the upcoming departure of William Fricker, Chief Financial Officer (CFO) and Treasurer. Mr. Fricker’s last day with the Company will be August 30, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.92

James Brandon was appointed as Comptroller and Acting Chief Financial Officer at NRX Pharmaceuticals, Inc..

Action: appointed
Role: Comptroller and Acting Chief Financial Officer

Exact text from the filing

James Brandon, who served as Comptroller and Acting CFO for NeuroRx, Inc. since inception through 2020, will resume those duties

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Alessandra Daigneault was appointed as Acting Treasurer at NRX Pharmaceuticals, Inc..

Action: appointed
Role: Acting Treasurer

Exact text from the filing

Alessandra Daigneault, the Company’s General Counsel and Corporate Secretary will serve as Acting Treasurer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

William Fricker departed as Chief Financial Officer (CFO) and Treasurer at NRX Pharmaceuticals, Inc..

Action: departed
Role: Chief Financial Officer (CFO) and Treasurer

Exact text from the filing

announced the upcoming departure of William Fricker, Chief Financial Officer (CFO) and Treasurer. Mr. Fricker’s last day with the Company will be August 30, 2021.

View on SEC.gov

NRX Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0000950142-21-002677

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.